Oscar Health (NYSE:OSCR) Stock Price Down 5.7% – Time to Sell?

Oscar Health, Inc. (NYSE:OSCR) was down 5.7% on Tuesday . The company traded as low as $17.03 and last traded at $17.05. Approximately 647,633 shares changed hands during trading, a decline of 80% from the average daily volume of 3,208,691 shares. The stock had previously closed at $18.09.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on OSCR. UBS Group began coverage on Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price on the stock. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a research note on Tuesday, September 10th. Three research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $24.00.

Oscar Health Trading Down 1.7 %

The stock’s fifty day simple moving average is $18.74 and its 200 day simple moving average is $18.43. The firm has a market capitalization of $4.30 billion, a PE ratio of -131.07, a PEG ratio of 34.96 and a beta of 1.67. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last released its earnings results on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The firm had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.13 billion. During the same quarter in the previous year, the firm earned ($0.07) earnings per share. The company’s quarterly revenue was up 44.6% compared to the same quarter last year. On average, sell-side analysts predict that Oscar Health, Inc. will post 0.01 earnings per share for the current year.

Insider Buying and Selling

In other Oscar Health news, CFO Richard Scott Blackley sold 68,978 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $1,240,914.22. Following the completion of the sale, the chief financial officer now directly owns 884,213 shares in the company, valued at $15,906,991.87. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the transaction, the insider now directly owns 76,982 shares of the company’s stock, valued at $1,384,906.18. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Richard Scott Blackley sold 68,978 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $1,240,914.22. Following the completion of the transaction, the chief financial officer now directly owns 884,213 shares in the company, valued at approximately $15,906,991.87. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 169,569 shares of company stock valued at $3,007,069 over the last three months. 25.11% of the stock is owned by company insiders.

Institutional Investors Weigh In On Oscar Health

Institutional investors have recently made changes to their positions in the stock. Assenagon Asset Management S.A. increased its stake in Oscar Health by 32.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock valued at $32,368,000 after buying an additional 507,009 shares during the period. FCG Investment Co purchased a new stake in shares of Oscar Health during the 3rd quarter worth approximately $986,000. Jupiter Asset Management Ltd. acquired a new position in shares of Oscar Health during the 1st quarter worth approximately $653,000. Toth Financial Advisory Corp raised its position in shares of Oscar Health by 73,185.7% during the 3rd quarter. Toth Financial Advisory Corp now owns 51,300 shares of the company’s stock worth $1,088,000 after purchasing an additional 51,230 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its position in shares of Oscar Health by 153.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock worth $59,156,000 after purchasing an additional 2,409,160 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.